The double-helix derailed: the story of the BRCA patent.

doi:10.1016/S0140-6736(10)61150-6

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The double-helix derailed: the story of the BRCA patent.

Lancet (London, England) - 31 Jul 2010

Matloff Ellen T, Brierley Karina L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1
Share to Genes, BRCA2
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Patents as Topic

Share to United States

Source

Open in PubMed

Identifiers

PMID: 20674708
DOI: 10.1016/S0140-6736(10)61150-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The double-helix derailed: the story of the BRCA patent.PMID 20674708Read ↗

[Revocation of the BRCA1 patents by the European Office of Patents: a victory over a rights abuse].Semantic proximity Read ↗

Flunk the gene test and lose your insurance.Semantic proximity Read ↗

Biomedicine. D-Day for BRCA2.Semantic proximity Read ↗

Law-medicine interfacing: patenting of human genes and mutations.Semantic proximity Read ↗

Torts and the double helix: malpractice liability for failure to warn of genetic risks.Semantic proximity Read ↗

Catastrophic revelations about Op18/stathmin.Semantic proximity Read ↗

p53 — a Jack of all trades but master of noneSemantic proximity Read ↗

DNA patents and diagnostics: not a pretty pictureSemantic proximity Read ↗

The inscription of life in law: genes, patents, and bio-politics.Semantic proximity Read ↗

The case for eteplirsen: Paving the way for precision medicine.Semantic proximity Read ↗

Playing the odds: health insurers want to know what's in your DNA.Semantic proximity Read ↗

23andMe and the FDA.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.